Vascular endothelial growth factor: How it transmits its signal

Experimental Nephrology

Volumn 6, Issue 6, 1998, Pages 480-487

  Zachary, Ian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Endothelium; Flk 1; Receptor tyrosine kinase; Signal transduction

Indexed keywords

PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

AMINO ACID SEQUENCE; ANGIOGENESIS; DIMERIZATION; HUMAN; KIDNEY DEVELOPMENT; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SECOND MESSENGER; SHORT SURVEY;

EID: 0031770547     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020560     Document Type: Short Survey

References (62)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31.
2. Risau W: Mechanisms of angiogenesis. Nature 1997;386:671-674.
3. Ferrara N, Houck KA, Jakeman LB, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32.
4. Park JE, Chen HH, Winer J, Houck KA, Ferrara N: Placenta growth factor Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high-affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994;269:25646-25654.
5. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996;93:2576-2581.
6. Joukov V, Pajusola K, Kaipainen A: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-298.
7. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. J Biol Chem 1991;266:11947- 11954.
8. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845.
9. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-848.
10. Takahashi A, Sasaki H, Sun Jim K, Tobisu KI, Kakizoc T, Tsukamoto T, Kumamoto Y, Sugimura T, Terada M: Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 1994;54:4233-4237.
11. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 175:1375-1379.
12. Stavri GT, Hong Y, Zachary IC, Breier G, Baskerville PA, Hla-Herttualla S, Risau W, Martin JF, Erusalimsky JD: Hypoxia and platelet- derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 1995;358:311-315.
13. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD: Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Circulation 1995;92:5-8.
14. Uchida K, Uchida S, Nitta K, Yumura W, Marumo F, Nihei H: Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor. Am J Physiol 1994; 266:F81-F88.
15. Takahashi T, Shirasawa T, Miyake K, Yahagi Y, Maruyama N, Kasahara N, Kawamura T, Matsumura O, Mitarai T, Sakai O: Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Commun 1995;209:218-226.
16. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor during embryonic angiogenesis. Cell 1996;87:1171-1180.
17. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM: Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon- injured rat carotid artery. Circulation 1995;91: 2793-2801.
18. Callow AD, Choi ET, Trachtenberg JD, Stevens SL, Connolly DT, Rodi C, Ryan US: Vascular permeability factor accelerates endothelial regrowth following balloon angioplasty. Growth Factors 1994;10:223-228.
19. 165 gene transfer. Circulation 1996;94: 3291-3302.
20. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-1028.
21. Simon M, Grone HJ, Johren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995;268:F240- F250.
22. Flamme I, Breier G, Risau W: Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev Biol 1995;169:699-712.
23. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest 1997;99:2351-2357.
24. Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA: Negative regulation of hypoxia- inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 1996;93:10595- 10599.
25. Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, Linehan WM: Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumour suppressor gene. Proc Natl Acad Sci USA 1996;93:10589-10594.
26. Kramer BK, Bucher M, Sandner P, Ittner KP, Riegger GAJ, Ritthaler T, Kurtz A: Effects of hypoxia on growth factor expression in the rat kidney in vivo. Kidney Int 1997;51:444-447.
27. Grone HJ, Simon M, Grone EF: Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 1995;177:259-267.
28. Clauss M, Gerlach H, Brett J, Wang F, Familetti PC, Pan Y-CE, Olander JV, Connolly DT, Stem D: Vascular permeability factor: A tumour-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 1990;172:1535-1545.
29. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W: The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J Biol Chem 1996; 271:17629-17634.
30. Barger AC, Beeuwkes R, Lainey LL, et al: Hypothesis: Vasa vasorum and neo-vascularisation of human coronary arteries. Possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310:175-178.
31. Geiringer E: Intimai vascularisation and atherosclerosis. J Pathol Bacteriol 1951;63:201- 211.
32. O'Brien ER, Garvin MR, Dev R, et al: Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994;145:883-894.
33. Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes J, Isner JM: Vascular endothelial growth factor/ vascular permeability factor (VEGF/VPF) in normal and atherosclerotic arteries. Am J Pathol 1997;150:1673-1685.
34. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
35. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase Res Commun 1992;187:1579- 1586.
36. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 1991;88:9026-9030.
37. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993;90:7533-7537.
38. Cao Y, Chen H, Zhou L, Chiang MK, Anand- Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Tsang ML: Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumour cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem 1996;271:3154-3162.
39. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, Ullrich A: High affinity binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993;72: 835-846.
40. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin C-H: Different signal transduction properties of KDR and Fit 1: Two receptors for vascular endothelial growth factor. J Biol Chem 1994;269:26988-26995.
41. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fit) closely related to the fms family. Oncogene 1990;5: 519-524.
42. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant. Nature 1994;367:576-579.
43. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman ML, Schuh AC: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376:62-66.
44. Fong G-H, Rossant J, Gertsenstein M, Breitman ML: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995;376:66-70.
45. Heldin C-H: Dimerization of cell surface receptors in signal transduction. Cell 1995;80:213- 223.
46. Dougher-Vermazen M, Hulmes JD, Bohlen P, Terman BI: Biological activity and phosphorylalion sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. Biochem Biophys Res Commun 1994;205:728- 738.
47. Pawson T: Protein modules and signalling networks. Nature 1995;373:573-580.
48. Guo D, Jia Q, Song H-Y, Warren RS, Donner DB: Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. J Biol Chem 1995;270:6729-6733.
49. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from FLT tyrosine kinase: A receptor for vascular endothelial growth factor VEGF. Oncogene 1995;10:135-147.
50. Xia P, Aiello LP Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jorousek MR, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996;98:2018- 2026.
51. Abedi H, Zachary I: Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 1997;272:15442-15451.
52. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 1991;138:213-221.
53. Cunningham SA, Waxham MN, Arrate PM, Brock TA: Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 1995; 270:20254-20257.
54. Ku DD, Zaleski JK, Liu S, Brock TA: Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993;265:H586-H592.
55. van der Zee R, Murohara T, Luo Z, Zollman F, Passen J, Lekutat C, Isner JM: Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997;95:1030-1037.
56. Ziche M, Morbidelli L, Choudhuri R, Zhang H-T, Donnim S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997;99:2625-2634.
57. Ahmed A, Dunk C, Kniss D, Wilkes M: Role of VEGF receptor-1 (Flt-1) in mediating calcium- dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 1997;76:779-791.
58. 2. J Biol Chem 1997;272: 16709-16712.
59. Moncada S: Biological importance of prostacyclin. Br J Pharmacol 1982;76:3-31.
60. Lüscher TF, Noll G: The endothelium as a regulator of vascular tone and growth; in Lüscher, TF (ed): The Endothelium in Cardiovascular Disease. Berlin, Springer, 1995, pp 1-24.
61. Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS: Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995;270:9709- 9716.
62. Ewasaka C, Tanaka K, Abe M, Sato Y: Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 1996;169:522-531.